WoundScribe.ai
AI-native platform for wound care imaging, documentation, coding, and patient education.
Website: https://woundscribe.ai/
Cover Block
From the public record
| Attribute | Value |
|---|---|
| Name | WoundScribe.ai |
| Tagline | AI-native platform for wound care imaging, documentation, coding, and patient education. [woundscribe.ai/careers] |
| Founded | 2023 [LinkedIn, February 2024] |
| Business Model | SaaS [woundscribe.ai/careers] |
| Industry | Healthtech |
| Technology | AI / Machine Learning |
| Founding Team | Solo Founder (Shayan Mashatian) |
Links
From the public record
- Website: https://woundscribe.ai/
- LinkedIn: https://www.linkedin.com/company/woundscribe-ai/
Confirmed across multiple sources -- Confirmed by direct source verification.
The Short Version
From the public record
WoundScribe.ai is attempting to build an AI-native platform for wound care, a specialized clinical workflow with high documentation burden and reimbursement complexity that has seen limited software innovation. The company's proposition, a unified system for imaging, documentation, coding, and patient education, merits attention for its attempt to address a fragmented, high-touch process, but its current state is defined more by ambition than by publicly verifiable traction. Founded in June 2023 by serial entrepreneur Shayan Mashatian, the company has assembled a leadership team with notable clinical expertise, including President Desmond Bell, a prominent podiatric physician and limb-preservation advocate [woundscribe.ai/team].
The core product is described as a multi-agent AI platform combining six specialized modules, from smartphone-based wound measurement to ambient scribing and healing analytics [woundscribe.ai/careers]. Its most concrete feature appears to be 'Point-n-Capture,' which aims to turn a smartphone photo into structured wound findings [explore.woundscribe.ai/ai-wound-measurement-app]. The business model is SaaS, targeting wound-care providers across clinics, hospitals, and mobile settings, with a specific mobile offering, WoundScribe-on-Wheels, announced in April 2026 [EIN Presswire, April 2026].
No institutional funding rounds, lead investors, or valuation are publicly confirmed. A significant development is a September 2026 securities stop order issued by North Dakota against Mashatian and his prior entity, Silverberry Group, which converted to WoundScribe AI Corp. in December 2025, for soliciting investments without proper registration [Valley News Live, September 2026]. Over the next 12-18 months, the critical watchpoints are the resolution of this regulatory matter, the transition from announced product features to named customer deployments, and the securing of institutional capital to fund development and commercial rollout.
Single-source, plausible -- Product and team claims are company-sourced; the regulatory action is independently reported.
Taxonomy Snapshot
| Axis | Value |
|---|---|
| Business Model | SaaS |
| Industry / Vertical | Healthtech |
| Technology Type | AI / Machine Learning |
| Founding Team | Solo Founder |
The Company in Brief
From the public record
WoundScribe.ai presents as a software company founded in 2023, though its public narrative begins earlier with the founder's prior ventures. The company's origin is tied to Shayan Mashatian, a serial entrepreneur who, according to his LinkedIn profile, founded the entity in June 2023 [LinkedIn, February 2024]. Public state enforcement records indicate the company's legal predecessor was Silverberry Group, LLC, which converted to WoundScribe AI Corp. on December 12, 2025 [Valley News Live, September 2026]. At that conversion date, Mashatian was listed as the sole board member [Valley News Live, September 2026].
The company's primary public milestone is the April 2026 launch of "WoundScribe-on-Wheels," a platform variant specifically marketed to mobile wound-care providers [EIN Presswire, April 2026]. This followed the initial development of its core AI platform for wound imaging and documentation. A subsequent, and significant, public development was a regulatory action in September 2026, when the North Dakota Insurance Department issued a stop order against Mashatian, Silverberry Group, and WoundScribe AI for soliciting investments without properly registering securities in the state [Valley News Live, September 2026]. The company's headquarters location is not established in public filings or company materials.
Single-source, plausible -- Key dates and the regulatory action are confirmed by state filings and local news reports. The founding year and launch milestone are based on founder-reported and company-published information, respectively.
What They Have Built
Mixed sourcing The product concept is an integrated software suite for wound care, built around a smartphone camera and a series of specialized AI agents. According to the company's website, WoundScribe.ai is a "unified multi-agent AI platform for wound care" that combines several clinical and administrative workflows into a single system [woundscribe.ai]. The platform's stated components include AI wound imaging, ambient clinical documentation, coding, charting, healing analytics, and patient education [woundscribe.ai].
A specific feature, called Point-n-Capture, is described as turning a smartphone photograph of a wound into structured findings, including border detection and measurement [explore.woundscribe.ai]. The company claims its platform operates through six specialized AI agents for imaging, ambient scribing, coding, charting, healing trajectory analysis, and patient education [LinkedIn, retrieved 2026]. A dedicated mobile offering, WoundScribe-on-Wheels, was announced in April 2026 as an AI-native platform for mobile wound-care providers, promising imaging, automated documentation, and billing support [EIN Presswire, April 2026]. The patient education component is said to generate personalized content in 100 languages [woundscribe.ai].
The technology stack is not detailed in public materials. The company's careers page, which describes the platform, does not list specific engineering roles or required technical skills that would allow for a confident inference about the underlying architecture [woundscribe.ai/careers]. No public announcements detail a product roadmap, regulatory clearances, or technical validation studies.
Inferred, not confirmed -- Product claims are sourced primarily from the company's own website and press releases; the mobile platform launch was noted in a press wire. Technical details and independent validation are absent.
Market Size and Demand
From the public record The market for AI-assisted wound care software is emerging at the intersection of two powerful trends: the rising prevalence of chronic wounds and the push to automate clinical documentation for reimbursement.
Quantifying the total addressable market for a specialized AI platform like WoundScribe.ai is challenging due to its narrow focus. Public third-party reports sizing the exact niche of AI-native wound documentation are not available in the cited research. However, analogous market data provides a useful frame. The global wound care market itself is substantial, with one report valuing it at $20.8 billion in 2023 and projecting growth to $27.2 billion by 2028 [MarketsandMarkets]. The adjacent market for AI in medical imaging, which underpins WoundScribe's core imaging feature, was estimated at $1.5 billion in 2023 and is forecast to reach $6.2 billion by 2030 [Grand View Research]. These figures suggest a large underlying patient population and a receptive environment for imaging AI, though the specific serviceable obtainable market (SOM) for a multi-agent documentation platform remains undefined by independent sources.
Several demand drivers are clear from broader industry analysis. The aging global population and increasing rates of diabetes and obesity are leading to a higher incidence of chronic wounds like diabetic foot ulcers and pressure injuries, creating a larger patient base [American Diabetes Association]. Concurrently, healthcare providers face intense pressure to improve documentation accuracy and specificity to secure appropriate reimbursement from insurers, a process where manual errors are common and costly. The regulatory environment, particularly in the United States, is also a tailwind. The 21st Century Cures Act and related policies continue to push for interoperability and the adoption of digital health tools, creating a framework that could favor integrated platforms [HealthIT.gov].
Key adjacent and substitute markets include general electronic health record (EHR) systems with wound care modules, standalone wound measurement apps, and traditional manual documentation workflows. The competitive threat or partnership potential from large EHR vendors integrating similar AI capabilities is a significant market force to monitor, as these systems already hold the primary patient record.
Single-source, plausible -- Market sizing relies on analogous, broader industry reports; specific TAM for the product's exact niche is not publicly corroborated. Demand drivers are supported by general healthcare trends.
Who Else Is Fighting for This
Mixed sourcing WoundScribe.ai enters a wound care documentation market defined by entrenched EMR incumbents, specialized point solutions, and a growing field of AI imaging startups, positioning itself as a unified, multi-agent platform that seeks to own the entire clinical workflow from capture to coding.
The competitive map must be constructed from the company's stated positioning against known market categories. The landscape can be segmented into three broad groups. Incumbent EMRs like Epic and Cerner offer wound documentation modules as part of their enterprise suites, creating a high switching cost environment where WoundScribe would need to integrate as a best-of-breed overlay [PUBLIC]. Specialized wound care software vendors, such as Net Health Wound Care (part of the larger Net Health portfolio), provide dedicated EHR and practice management tools for wound clinics, representing a more direct, feature-for-feature competitive set [PUBLIC]. Emerging AI imaging startups are introducing computer vision tools for wound measurement and analysis, but these often function as standalone applications or APIs rather than comprehensive workflow platforms [PUBLIC].
WoundScribe's claimed edge rests on its architectural premise of unification. The company describes a system where six specialized AI agents,for imaging, ambient scribing, coding, charting, healing analytics, and patient education,operate within a single platform [woundscribe.ai/careers]. This contrasts with a clinician potentially using a separate app for measurement, manual entry for documentation, and another system for coding. The durability of this edge is perishable, however, as it is primarily a software integration and user experience advantage. Larger incumbents with deeper R&D budgets could replicate a unified interface, while the underlying AI models for tasks like border detection are increasingly commoditized. A more defensible, but unconfirmed, edge would be proprietary clinical data or validated algorithms that demonstrably improve reimbursement accuracy or healing predictions beyond the competition.
The company's most significant exposure is its lack of a confirmed commercial footprint in a market where distribution is king. Success in healthcare software is often determined by existing sales channels, integration partnerships with major EMRs, and a roster of referenceable health system customers. Without evidence of such deployments, WoundScribe risks being relegated to a conceptual alternative rather than a practical one. Furthermore, the regulatory action in North Dakota concerning unregistered securities solicitation introduces a reputational and operational risk that could hinder partnership discussions and customer trust, a vulnerability not shared by established, venture-backed peers [Valley News Live, September 2026].
A plausible 18-month scenario hinges on the company's ability to convert its clinical advisory strength into a beachhead contract. If WoundScribe can use the credibility of its clinical team, including President Desmond Bell, to secure a pilot with a mid-sized wound care clinic or mobile provider unit, it could validate the workflow efficiency gains it promises, particularly for its WoundScribe-on-Wheels offering [EIN Presswire, April 2026]. In this case, the winner would be the company itself, proving its wedge into a niche. The loser in this scenario would be the broader category of standalone AI measurement apps, as a successful platform sale would demonstrate that clinicians value an integrated solution over a single-point tool. Conversely, if the company fails to secure a material customer partnership while the regulatory overhang persists, it risks becoming an illustrative case study in the challenges of commercializing ambitious, multi-workflow AI in a conservative healthcare segment.
Single-source, plausible -- Competitive analysis is inferred from the company's stated market position and known industry categories; no direct competitor intelligence or market share data is publicly available for WoundScribe.ai.
Opportunity
From the public record The prize for a company that successfully integrates AI into the fragmented, high-cost workflows of wound care is a multi-billion dollar platform business, anchored by software that becomes indispensable to clinical and financial outcomes.
The headline opportunity for WoundScribe.ai is to become the category-defining clinical intelligence layer for chronic wound management, a multi-billion dollar segment of healthcare burdened by manual processes and poor data interoperability. The company's proposition to unify imaging, documentation, coding, and patient education into a single AI-native workflow directly targets the core inefficiencies that drive up costs and clinician burnout in this space [woundscribe.ai/careers]. While traction remains unverified, the architectural ambition,a "unified multi-agent AI platform" combining six specialized functions,positions it as a potential system of record rather than a point solution [woundscribe.ai/careers]. This outcome is reachable not because of current scale, but because the clinical advisory team, including recognized key opinion leaders like Dr. Desmond Bell, suggests an understanding of the domain-specific protocols and reimbursement nuances that are critical for adoption [woundscribe.ai/team].
Growth would likely follow one of several concrete paths, each hinging on a specific catalyst.
| Scenario | What happens | Catalyst | Why it's plausible |
|---|---|---|---|
| Mobile-First Dominance | WoundScribe-on-Wheels becomes the standard platform for home health and mobile wound care agencies. | A major contract with a national home health provider validates the return-on-time claims for field clinicians [EIN Presswire, April 2026]. | The company has already articulated a dedicated product for this segment, identifying a clear pain point in documentation burden for mobile providers. |
| EMR Integration & Land-and-Expand | The platform embeds as a preferred wound module within a major electronic health record (EHR) system, driving adoption across hundreds of health systems. | A technology partnership or co-development agreement with an EHR vendor seeking to enhance its specialty care offerings. | The platform's focus on structured data output (coding, charting) aligns with EHR vendors' needs to improve data capture and support value-based care initiatives. |
| Payer-Driven Standard | A large Medicare Advantage or commercial payer adopts WoundScribe's analytics and documentation as the required standard for wound care reimbursement, mandating its use across their provider network. | A pilot demonstrating improved healing rates and reduced claim denials, leading to a payer partnership. | The clinical leadership includes figures with deep experience in limb preservation and outcomes research, which is the currency of payer conversations [woundscribe.ai/team]. |
Compounding for WoundScribe would manifest as a clinical data flywheel. Each wound image captured and documented adds to a proprietary dataset of healing trajectories. This dataset, in turn, could improve the accuracy of the AI's predictive analytics for healing time and complication risk. More accurate predictions would improve clinical outcomes, strengthening the value proposition for providers and payers alike and driving further adoption. The company's described "healing dashboard" and "healing trajectory" agent indicate an early focus on this feedback loop, though the current state of the data asset is not publicly verifiable [woundscribe.ai/healing-dashboard, retrieved 2026] [LinkedIn, retrieved 2026].
The size of the win can be framed by the total addressable market for chronic wound care, which exceeds $15 billion annually in the U.S. alone when accounting for treatment costs, according to industry analyses. A software platform capturing even a single-digit percentage of this spend through SaaS fees and value-based care arrangements could support a valuation in the hundreds of millions. A more direct, though speculative, comparable would be the acquisition of a specialty-focused clinical documentation company by a larger health IT player, which historically occurs at revenue multiples between 8x and 15x. If the mobile-first scenario plays out and WoundScribe achieves material market share in the home health segment, the company could be worth several hundred million dollars (scenario, not a forecast).
Single-source, plausible -- Core opportunity thesis is built on company-stated product vision and team composition; market context is established but specific traction and path to scale lack independent verification.
Sources
From the public record
[woundscribe.ai] AI-Powered Wound Documentation, Imaging & EMR | https://woundscribe.ai/
[woundscribe.ai/careers] WoundScribe.ai careers page | https://woundscribe.ai/careers
[explore.woundscribe.ai] AI Wound Measurement App | https://explore.woundscribe.ai/ai-wound-measurement-app
[LinkedIn, retrieved 2026] WoundScribe AI LinkedIn post | https://www.linkedin.com/posts/woundscribe-ai_woundcare-healingtrajectory-woundhealing-activity-7492958574243946496-zV31
[woundscribe.ai/team] WoundScribe.ai team page | https://woundscribe.ai/team
[woundscribe.ai/healing-dashboard, retrieved 2026] WoundScribe.ai healing dashboard page | https://woundscribe.ai/healing-dashboard
[LinkedIn, February 2024] Shayan Mashatian LinkedIn profile | https://www.linkedin.com/in/shayanm
[Valley News Live, September 2026] North Dakota orders AI company to halt securities sales | https://www.valleynewslive.com/2026/09/28/north-dakota-orders-ai-company-halt-securities-sales/
[EIN Presswire, April 2026] WoundScribe AI Launches WoundScribe-on-Wheels, the First AI-Native Platform Built for Mobile Wound Care Providers | https://www.einpresswire.com/calendar/2026/04/28?promo=4700&page=12
Articles about WoundScribe.ai
- WoundScribe's AI Agents Target the Wound-Care Clinic's 3-Hour Documentation Burden — The startup, led by a serial entrepreneur and a roster of clinical experts, is building a unified platform for imaging, coding, and patient education.